F

Fate Therapeutics

San Diego, United States Founded 2007 NASDAQ: FATE

About

iPSC-derived cell therapies including NK and T cells

Company Details

Type
public
Employees
500+
Funding
Public

Key Products

  • iPSC NK Cells
  • CAR-NK
Visit Website

Related Companies